---
title: "HARSON: Titanium alloy powder products have successfully passed pilot testing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262182954.md"
description: "On October 22nd, HARSON stated on the interactive platform that its secondary holding subsidiary, HARSON Weite, has successfully completed pilot testing of titanium alloy powder products produced using NPA technology and TPR technology. These products can be applied in the 3D printing and MIM industries"
datetime: "2025-10-22T07:52:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262182954.md)
  - [en](https://longbridge.com/en/news/262182954.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262182954.md)
generator: "portal-rs"
---

# HARSON: Titanium alloy powder products have successfully passed pilot testing

On October 22nd, HARSON stated on the interactive platform that its secondary holding subsidiary, HARSON Weite, has successfully completed pilot testing of titanium alloy powder products produced using NPA technology and TPR technology. These products can be applied in the 3D printing and MIM industries

### Related Stocks

- [603958.CN](https://longbridge.com/en/quote/603958.CN.md)

## Related News & Research

- [Revolut takes step closer to US bank launch after clearing key regulatory hurdle](https://longbridge.com/en/news/297933534.md)
- [Air China GAAP EPS of -RMB 0.13, revenue of RMB 89.27B](https://longbridge.com/en/news/297480690.md)
- [Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule](https://longbridge.com/en/news/297892535.md)
- [REG - Shuka Minerals PLC - Further re Subscription](https://longbridge.com/en/news/297867499.md)
- [Biocytogen licenses fully human VHH antibody to Qilu Pharma in non-exclusive deal](https://longbridge.com/en/news/297781804.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**